Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

计划入组 21 人 · 首次发布于 2026 年 3 月 5 日

PETHEMA-BLIN-01/PET069014 (BLIN-01)

计划入组 11 人 · 首次发布于 2018 年 5 月 14 日

Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

计划入组 14 人 · 首次发布于 2010 年 12 月 3 日

allogenic hNSC therapy (intracerebroventricular, multiple sclerosis)

INSC-01

hNPC-01

01 Communique Laboratory Inc

Canada

Miragen Therapeutics, Inc.

Renovaro

United States

First Patient Receives Neural Stem Cell Therapy in Pioneering Huntington's Disease Trial at UCI Health

UC Irvine Receives $12 Million Grant for First-in-Human Huntington's Disease Stem Cell Trial

Kiromic BioPharma's Deltacel Shows Promise in NSCLC Trial, Moves to Dose Expansion